Robeco Institutional Asset Management
KNSA icon

Robeco Institutional Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Robeco Institutional Asset Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,436
Closed -$233K – 884
2025
Q2 		$233K Buy
+8,436
New +$215K ﹤0.01% 844
2024
Q3 		– Sell
-15,982
Closed -$298K – 932
2024
Q2 		$298K Hold
15,982
– – ﹤0.01% 876
2024
Q1 		$315K Buy
15,982
+15,863
+13,330% +$310K ﹤0.01% 882
2023
Q4 		$2.09K Buy
+119
New +$1.96K ﹤0.01% 1081

Other funds holding KNSA

RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return